Overview Quote
Stock Activity
| Day Low - High | 48.93 - 49.92 |
| 52wk Low - High | 28.53 - 50.35 |
| Previous Close | 49.07 |
| Avg. Volume | 5,503,789 |
| Industry | RETAIL-DRUG STR |
| Market Cap | 46.49 B |
| Div - Yield | 1.10 - 2.24 |
| Beta | 1.07 |
| PE (Forward) | 15.02 |
| Current Year Est. | 3.27 |
| Quarterly Earnings ESP |
1.11% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
25 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Company Description
Walgreen Co. is a national retail pharmacy chain and considered the leader in innovative drugstore retailing. Walgreens pioneered many store features that are becoming standards in the industry. Among those concepts are: Computerized pharmacies, Point-of-sale scanning, Freestanding stores with drive-thru pharmacies, and Intercom Plus, Walgreens advanced new pharmacy computer and workflow system. Intercom Plus allows pharmacists to spend more time counseling patients by assigning administrative tasks to pharmacy technicians
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Earnings Estimates
| Current Qtr (05/2013) |
Next Qtr (08/2013) |
Current Year (08/2013) |
Next Year (08/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.90 | 0.82 | 3.27 | 3.64 |
| Number of Estimates | 12 | 12 | 12 | 14 |
| Low Estimate | 0.79 | 0.75 | 3.17 | 3.08 |
| High Estimate | 0.94 | 0.91 | 3.35 | NA |
| Year Ago EPS | 0.62 | 0.53 | 2.71 | 3.27 |
| EPS Growth | 45.43% | 53.93% | 20.57% | 11.38% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| WALGREEN CO | WAG | 49.07 | ![]() |
![]() |
| CHINA NEPSTAR | NPD | 1.66 | ![]() |
![]() |
| GNC HOLDINGS | GNC | 45.51 | ![]() |
![]() |
| HERBALIFE LTD | HLF | 43.23 | ![]() |
![]() |
| RITE AID CORP | RAD | 2.55 | ![]() |
![]() |
| AMERISOURCEBRGN | ABC | 54.48 | ![]() |
![]() |
| BIOSCRIP INC | BIOS | 13.75 | ![]() |
![]() |
| CARDINAL HEALTH | CAH | 46.16 | ![]() |
![]() |
| CVS CAREMARK CP | CVS | 58.55 | ![]() |
![]() |
| MCKESSON CORP | MCK | 114.61 | ![]() |
![]() |
Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR
Zacks Commentary
Pernix Reports Loss in 1Q
May 13, 2013
Focus Shifts to Retail Earnings
May, 10 2013 00:00
Will DENTSPLY Beat Earnings in 1Q?
May 08, 2013
Another Month of Plump Sales for WAG
May 06, 2013
Federal Realty Beats Earnings
May 06, 2013
The Zacks Analyst Blog Highlights: Rite Aid, Walgreen, CVS Caremark, Wal-Mart Stores and inTEST
May 06, 2013
Rite Aid's April Comps Fall
May 03, 2013
Will CVS Earnings Miss this Quarter?
Apr 30, 2013
Financials
| EPS TTM | 2.69 |
| Sales | 71,633 |
| Net Income | 2,059 |
| Price/Earnings | 18.24 |
| Price/Book | 2.44 |
| Price/Cash Flow | 13.07 |
| Price/Sales | 0.66 |
News
Is Walgreen`s Stock Still Worth Owning? - TheMotleyFool
May 14, 2013
Rite Aid is Among the Companies in the Drug Retail Industry With the Highest EBITDA Growth (RAD, WAG, CVS) - Financial News Network Online - News Corner
May 14, 2013
Walgreens extends agreement as a CVS Caremark Network Provider - M2
May 14, 2013
3 Must-Own Stocks from Barron`s Insider Buying List - TheMotleyFool
May 13, 2013
OraSure Technologies, Walgreens and Chronic Liver Disease Foundation to Launch Rapid Hepatitis C Testing Initiative in Support of National Hepatitis Testing Day - Globenewswire
May 13, 2013
Walgreen Co.Corporate Event Announcement Notice - Wall Street Horizon
May 13, 2013
Walgreen has starring role in 'Celebrity Apprentice' finale - Mcclatchy-Tribune Information Services -- Unrestricted
May 13, 2013
Walgreen, CVS Extend Multi-Year Pharmacy Network Deal - FOXBusiness.com
May 13, 2013
Broker Recommendations
| Current ABR | 1.88 |
| ABR (Last Week) | 1.88 |
| # of recs in ABR | 16 |
| Average Target Price | 46.69 |
| Industry Rank by ABR | 25 out of 265 |
| Rank in Industry | 5 out of 11 |

